Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,501–1,600 of 2,883
Fleyshman, D. I., Wakshlag, J. J., Huson, H. J., Loftus, J. P., Olby, N. J., Brodsky, L., Gudkov, A. V., & Andrianova, E. L. (2021) · Aging · doi:10.18632/aging.203600 · Cited by 19
Decreased thymic output predicts progression of chronic kidney disease
Iio, K., Kabata, D., Iio, R., Shibamoto, S., Watanabe, Y., Morita, M., Imai, Y., Hatanaka, M., Omori, H., & Isaka, Y. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00333-z · Cited by 19
Telomeres Increasingly Develop Aberrant Structures in Aging Humans
Boccardi, V., Cari, L., Nocentini, G., Riccardi, C., Cecchetti, R., Ruggiero, C., Arosio, B., Paolisso, G., Herbig, U., & Mecocci, P. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly257 · Cited by 17
Premature aging in genetic diseases: what conclusions can be drawn for physiological aging
Milosic, F., Hengstschläger, M., & Osmanagic‐Myers, S. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1327833 · Cited by 25
Wan, X., Li, C., Tan, Y. H., Zuo, S., Deng, F. M., Sun, J. F., & Liu, Y. L. (2024) · Cell Biology International · doi:10.1002/cbin.12143 · Cited by 21
“A study performed by Baker et al. revealed that clearing senescent cells can extend the healthspan in mice (Baker et al., 2016), and this is consistent with our findings.”
ResultTenovin-1 Induces Senescence and Decreases Wound-Healing Activity in Cultured Rat Primary Astrocytes
Bang, M., Ryu, O., Kim, D. G., Mabunga, D. F., Cho, K. S., Kim, Y., Han, S.-H., Kwon, K. J., & Shin, C. Y. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.107 · Cited by 17
Mitin, N., Nyrop, K. A., Strum, S. L., Knecht, A., Carey, L. A., Reeder-Hayes, K. E., Dees, E. C., Jolly, T. A., Kimmick, G. G., Karuturi, M. S., et al. (2022) · doi:10.1101/2022.02.10.22270086 · Cited by 17
Neuroimmune interactions in Alzheimer's disease—New frontier with old challenges?
Prokop, S., Lee, V. M. ‐., & Trojanowski, J. Q. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.10.002 · Cited by 19
Patra, M., Klochendler, A., Condiotti, R., Kaffe, B., Elgavish, S., Drawshy, Z., Avrahami, D., Narita, M., Hofree, M., Drier, Y., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae313 · Cited by 18
Immune Diseases Associated with Aging: Molecular Mechanisms and Treatment Strategies
Kim, M. E., & Lee, J. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115584 · Cited by 26
“The SASP has certain positive effects, including enabling the immune system’s recruitment to premalignant lesions and encouraging the repair of injured tissues [60–62].”
BackgroundHuman Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions
Chmielewski, P. P., Data, K., Strzelec, B., Farzaneh, M., Anbiyaiee, A., Zaheer, U., Uddin, S., Sheykhi-Sabzehpoush, M., Mozdziak, P. E., Zabel, M., et al. (2024) · Aging and Disease · doi:10.14336/ad.2024.0280 · Cited by 37
Mandl, M., Wagner, S., Hatzmann, F. M., Ejaz, A., Ritthammer, H., Baumgarten, S., Viertler, H. P., Springer, J., Zwierzina, M., Mattesich, M., et al. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa098 · Cited by 18
Nanocarriers targeting senescent cells
Muñoz‐Espín, D. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.01.001 · Cited by 18
The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype
(2018) · doi:10.1101/466755 · Cited by 154
Senescence in the ageing skin: a new focus on m TORC 1 and the lysosome
Smith, P., & Carroll, B. (2024) · FEBS Journal · doi:10.1111/febs.17281 · Cited by 21
“…1. negatively impacts tissues via a variety of mechanisms, for example through secretion of inflammatory factors, and their significance in ageing is exemplified by the observation that senescent cell clearance in mouse models leads to an extension in their healthy lifespan (‘healthspan’) [3,4].”
Mitochondria-driven elimination of cancer and senescent cells
Hubáčková, S., Novais, S. M., Davidová, E., Neužil, J., & Rohlena, J. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0256 · Cited by 20
Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: A case report
Jeong, A., Forbes, K., Orosco, R. K., & Cohen, E. E. W. (2022) · Journal of Otolaryngology - Head and Neck Surgery · doi:10.1186/s40463-022-00556-y · Cited by 19
The Potential of Senescence as a Target for Developing Anticancer Therapy
Jo, H., Shim, K., & Jeoung, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043436 · Cited by 20
Intracellular acidification and glycolysis modulate inflammatory pathway in senescent cells
Kawakami, S., Johmura, Y., & Nakanishi, M. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae032 · Cited by 16
“For example, in INK-ATTAC mice, an engineered caspase-8-FKBP fusion protein and GFP were expressed under the p16 promoter ( 2 ).”
BackgroundSharma, R. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.3970 · Cited by 20
“21,22 Interestingly, a recent study revealed that the known exceptional longevity and resistance to age ‐ related decline in naked mole rats can be attributed to their natural removal of accumulated senescent cells.”
Aging in Ocular Blood Vessels: Molecular Insights and the Role of Oxidative Stress
Cui, X., Buonfiglio, F., Pfeiffer, N., & Gericke, A. (2024) · Biomedicines · doi:10.3390/biomedicines12040817 · Cited by 17
“Eliminating senescent cells expressing p16INK4A has been shown to extend the lifespan and health span of mice [13].”
BackgroundExtension of C. elegans lifespan using the ·NO-delivery dinitrosyl iron complexes
Huang, H.-W., Lin, Y.-H., Lin, M.-H., Huang, Y.-R., Chou, C., Hong, H.-C., Wang, M.-R., Tseng, Y.-T., Liao, P.-C., Chung, M.-C., et al. (2018) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-018-1569-1 · Cited by 19
Addressing osteoblast senescence: Molecular pathways and the frontier of anti‐ageing treatments
Zhang, Z., Liu, P., Song, Y., Ma, L., Xu, Y., Lei, J., Tong, B., Zhu, D., Liang, H., Wang, H., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70417 · Cited by 26
Compression of morbidity by interventions that steepen the survival curve
Yang, Y., Mayo, A., Levy, T., Raz, N., Shenhar, B., Jarosz, D. F., & Alon, U. (2025) · Nature Communications · doi:10.1038/s41467-025-57807-5 · Cited by 18
Targeting multiple hallmarks of mammalian aging with combinations of interventions
Panchin, A. Y., Ogmen, A., Blagodatski, A. S., Egorova, A., Batin, M., & Glinin, T. S. (2024) · Aging · doi:10.18632/aging.206078 · Cited by 25
Luca, S. N. D., & Vlahos, R. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16263 · Cited by 23
“Transplant-ing senescent cells into elderly mice resulted in increased organ failure and mortality (Xu et al., 2018), whereas eliminating naturally occurring senescent cells increased the lifespan of normally ageing mice (Baker et al., 2016;).”
BackgroundAssessment and consequences of cell senescence in atherosclerosis
Garrido, A. M., & Bennett, M. R. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000327 · Cited by 19
Mitin, N., Nyrop, K. A., Strum, S. L., Knecht, A. K., Carey, L., Reeder-Hayes, K. E., Dees, E. C., Jolly, T. A., Kimmick, G. G., Karuturi, M. S., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00473-3 · Cited by 19
Palikyras, S., Sofiadis, K., Stavropoulou, A., Danieli‐Mackay, A., Varamogianni‐Mamatsi, V., Hörl, D., Nasiscionyte, S., Zhu, Y., Papadionysiou, I., Papadakis, A., et al. (2024) · Aging Cell · doi:10.1111/acel.14083 · Cited by 17
Muscle stem cell aging: identifying ways to induce tissue rejuvenation
Sousa‐Victor, P., Neves, J., & Muñoz‐Cánoves, P. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111246 · Cited by 22
p53 Regulates Mitochondrial Dynamics in Vascular Smooth Muscle Cell Calcification
Phadwal, K., Tang, Q., Luijten, I. H. N., Zhao, J., CORCORAN, B. M., Semple, R. K., Ganley, I. G., & MacRae, V. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021643 · Cited by 21
“Our data reveal that under calcifying culture conditions, murine VSMCs upregulate the expression of senescence markers, including p53, p21 and SA-β-gal, supporting and extending previous work in human cells and demonstrating that cellular senescence impacts vascular aging and arterial calcification [31].”
BackgroundZeng, N., Guo, C., Wang, Y., Li, L., Chen, X., Gao, S., Jiang, F., & Cao, B. (2022) · Journal of Oncology · doi:10.1155/2022/1271378 · Cited by 23
Sogabe, Y., Seno, H., Yamamoto, T., & Yamada, Y. (2018) · Cancer Science · doi:10.1111/cas.13731 · Cited by 17
Tools to eliminate senescent cells
Serrano, M. (2017) · Nature · doi:10.1038/nature22493 · Cited by 19
Senolytic therapies for cardiovascular aging: tackling fibrosis and metabolic dysfunction
Atlante, S., Zamperla, M. G., Cis, L., Farsetti, A., & Gaetano, C. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.07.009 · Cited by 25
Morales-Valencia, J., & David, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.747822 · Cited by 21
Rejuvenation: Turning back the clock of aging kidney
Wei, S.-Y., Pan, S., Li, B., Chen, Y., & Lin, S. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.05.020 · Cited by 19
Francis, T., Jaka, O., Ellison, G. M., Lazarus, N. R., & Harridge, S. D. R. (2022) · JCSM Rapid Communications · doi:10.1002/rco2.67 · Cited by 18
Senescent macrophages: A new “old” player in lung cancer development
Zhou, L., & Ruscetti, M. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.05.008 · Cited by 19
Homologous recombination-mediated irreversible genome damage underlies telomere-induced senescence
Ghadaouia, S., Olivier, M., Martinez, A., Kientega, T., Jian, Q., Lambert-Lanteigne, P., Cardin, G. B., Autexier, C., Malaquin, N., & Rodier, F. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab965 · Cited by 19
Senescent Phenotype of Astrocytes Leads to Activation of BV2 Microglia and N2a Neuronal Cells Death
Zhang, Y. W., Yang, X., Liu, J., Pan, Y., Zhang, M., & Chen, L. (2022) · Molecules · doi:10.3390/molecules27185925 · Cited by 22
“Recent studies have demonstrated that the clearance of senescent cells results in prolonged life span in mice [1].”
BackgroundCellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Lim, H. A., Kwon, Y. S., Kim, D., Lee, J., & Kim, H. P. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153255 · Cited by 18
Potential of Hibiscus sabdariffa L. and Hibiscus Acid to Reverse Skin Aging
Wang, D., Nagata, M., Matsumoto, M., Amen, Y. M., Wang, D., & Shimizu, K. (2022) · Molecules · doi:10.3390/molecules27186076 · Cited by 26
Puerarin blocks the aging phenotype in human dermal fibroblasts
Kamiya, Y., Odama, M., Mizuguti, A., Murakami, S., & Ito, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249367 · Cited by 17
Implications of Cellular Aging in Cardiac Reprogramming
Passaro, F., & Testa, G. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00043 · Cited by 16
Divergent mechanisms of metabolic dysfunction drive fibroblast and T-cell senescence
Callender, L. A., Carroll, E. C., Bober, E. A., & Henson, S. M. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.06.001 · Cited by 18
Nishida, Y., Terkawi, M. A., Matsumae, G., Yokota, S., Tokuhiro, T., Ogawa, Y., Ishizu, H., Shiota, J., Endo, T., Alhasan, H., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.182418 · Cited by 20
“Indeed, there is solid evidence from experimental aging models that senotherapeutics represent a powerful antiaging strategy in that it delays the onset of chronic diseases associated with aging, improves the function of organs, and extends healthspan (39–43).”
Regulatory coupling between long noncoding RNAs and senescence in irradiated microglia
Xu, A., Li, R., Ren, A., Jian, H., Huang, Z., Zeng, Q., Wang, B., Zheng, J., Chen, X., Zheng, N., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02001-1 · Cited by 21
Parshad, B., Baker, A. G., Ahmed, I., Estepa‐Fernández, A., Muñoz‐Espín, D., & Fruk, L. (2024) · Small · doi:10.1002/smll.202405732 · Cited by 21
Spagnolo, P., & Semenzato, U. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000876 · Cited by 21
Wu, T., Wu, Y., Jiang, D., Sun, W., Zou, M., Vasamsetti, S. B., Dutta, P., Leers, S. A., Wu, D., & Li, G. (2023) · Aging Cell · doi:10.1111/acel.13765 · Cited by 18
“…mouse model or a mouse model with accelerated aging using genetic manipulation or synolytic reagents eliminate senescent cells in different organs and tissues, which delays age- related diseases and extends healthy life span (Baker et al., 2011, 2016; Dang et al., 2020; Hickson et al., 2019).”
BackgroundA focused natural compound screen reveals senolytic and senostatic effects of Isatis tinctoria
Kim, E.-J., Woo, J., Shin, S., Choi, H., Kim, Y. S., Kim, J., & Kang, C. (2022) · Animal Cells and Systems · doi:10.1080/19768354.2022.2143895 · Cited by 17
“More importantly, genetic elimination of senescent cells improves several age-related pathologies and extends lifespan in mice (Baker et al. 2016).”
BackgroundChen, Z., Li, X., Sun, X., Xiao, S., Chen, T., Ren, L., & Liu, N. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.010 · Cited by 21
Mao, R., Wang, Y., Wang, F., Zhou, L., Yan, S., Lu, S., Shi, W., & Zhang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.881051 · Cited by 17
“In vivo, senescence is an important mechanism to prevent damaged cells from transforming into tumor cells (Baker et al., 2016), and plays an important physiological role in wound healing (Demaria et al., 2014).”
BackgroundBiomarkers of senescence in non-human primate adipose depots relate to aging
Kavanagh, K., Sherrill, C., Ruggiero, A. D., Block, M. R., Vemuri, R., Davis, M., & Olivier, A. (2020) · GeroScience · doi:10.1007/s11357-020-00230-z · Cited by 20
Cellular senescence by loss of Men1 in osteoblasts is critical for age‐related osteoporosis
Ukon, Y., Kaito, T., Hirai, H., Kitahara, T., Bun, M., Kodama, J., Tateiwa, D., Nakagawa, S., Ikuta, M., Furuichi, T., et al. (2024) · Aging Cell · doi:10.1111/acel.14254 · Cited by 17
“Accumulating evidence highlights a close relationship between age-related diseases and cellular senescence 5–7 , which was discovered by Hay�ick et al. 8 and is de�ned by an irreversible cell growth arrest regulated through the p16 ink4a /RB and p53/p21 CIP1 pathways 9 .”
BackgroundGuerrero, A., Innes, A. J., Roux, P., Buisman, S. C., Jung, J., Ortet, L., Moiseeva, V., Wagner, V., Robinson, L. J., Ausema, A., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00279-9 · Cited by 15
Elimination of Senescent Cells: Prospects According to the Subtelomere-Telomere Theory
Libertini, G., Ferrara, N., Rengo, G., & Corbi, G. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120064 · Cited by 19
Tilman, G., Bouzin, C., Aydın, S., Tamirou, F., Galant, C., Coulie, P. G., Houssiau, F., Lauwerys, B., & Limaye, N. (2021) · RMD Open · doi:10.1136/rmdopen-2021-001844 · Cited by 19
Huang, E., Ma, T., Zhou, J., Ma, N., Yang, W.-S., Liu, C., Hou, Z., Chen, S., Castria, T. B. D., Zeng, B., et al. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-3348 · Cited by 19
p21 facilitates chronic lung inflammation via epithelial and endothelial cells
Levi, N., Papismadov, N., Majewska, J., Roitman, L., Wigoda, N., Eilam, R., Tsoory, M., Rotkopf, R., Ovadya, Y., Akiva, H., et al. (2023) · Aging · doi:10.18632/aging.204622 · Cited by 15
“Indeed, senescent cells elimination via transgenic techniques improves aging-associated phenotypes [31, 38, 86].”
Therapy-induced normal tissue damage promotes breast cancer metastasis
Perkins, D. W., Steiner, I., Haider, S., Robertson, D. M., Buus, R., O’Leary, L., & Isacke, C. M. (2023) · iScience · doi:10.1016/j.isci.2023.108503 · Cited by 21
Nectin-4 regulates cellular senescence-associated enlargement of cell size
Katasho, R., Nagano, T., Iwasaki, T., & Kamada, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-48890-z · Cited by 17
Yu, Y. C.-Y., Hui, T., Kao, T.-H., Liao, H., Yang, C.-Y., Hou, C., Hsieh, H.-T., Chang, J., Tsai, Y., Pinskaya, M., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00103 · Cited by 17
Targeting Senescent Cells as Therapy for CKD
Mylonas, K. J., & Ferenbach, D. A. (2023) · Kidney360 · doi:10.34067/kid.0000000000000316 · Cited by 23
“29 Experimental work from our own laboratory and other groups 30 – 32 has demonstrated a role for senescent epithelial cells in the evolution of kidney disease (Figure 2).”
BackgroundLaliberté, C., Bossé, B., Bourdeau, V., Prieto, L. I., Perron-Deshaies, G., Vuong, N., Igelmann, S., Aguilar, L. C., Oeffinger, M., Baker, D. J., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12051089 · Cited by 22
“More importantly, the elimination of senescent cells extends the healthy lifespan of old mice and prevents some age-related conditions [22,23].”
BackgroundSelf-citationThe Roles of Myeloid Cells in Aging-related Liver Diseases
Yao, J., Li, Y., & Wang, H. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82352 · Cited by 18
“Elimination of senescent cells by gene editing prevents or delays tissue dysfunction and extends healthy lifespan, suggesting that immunosurveillance and clearance of senescent cells can help ameliorate aging-related diseases [112, 113].”
BackgroundSegmental Aging Underlies the Development of a Parkinson Phenotype in the AS/AGU Rat
Khojah, S. M., Payne, A., McGuinness, D., & Shiels, P. G. (2016) · Cells · doi:10.3390/cells5040038 · Cited by 16
Endometrial senescence is mediated by interleukin 17 receptor B signaling
Kawamura, K., Matsumura, Y., Kawamura, T., Araki, H., Hamada, N., Kuramoto, K., Yagi, H., Onoyama, I., Asanoma, K., & Kato, K. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01740-5 · Cited by 22
Huang, E., Ma, T., Zhou, J., Ma, N., Yang, W.-S., Liu, C., Hou, Z., Chen, S., Zong, Z., Zeng, B., et al. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-721 · Cited by 18
The Regulation of Cellular Senescence in Cancer
Zhang, X., Gao, Y., Zhang, S., Wang, Y., Du, Y., Hao, S., & Ni, T. (2025) · Biomolecules · doi:10.3390/biom15030448 · Cited by 17
“DCs originate from hematopoietic stem cells in the bone marrow, circulate in the blood, and reside in tissues where potential antigens are encountered [69].”
Sáez, T., Spaans, F., Kirschenman, R. D., Sawamura, T., & Davidge, S. T. (2020) · Clinical Science · doi:10.1042/cs20200764 · Cited by 14
Identification of Prominin‐2 as a new player of cardiomyocyte senescence in the aging heart
Maggiorani, D., Santin, Y., Formoso, K., Drapé, E., Martini, H., Brun, S., Cousin, G., Lairez, O., Lezoualc’h, F., Parini, A., et al. (2024) · Aging Cell · doi:10.1111/acel.14204 · Cited by 15
“…on the genetic or pharmacological (senolysis) elimination of senescent cells have provided the first demonstrations of their detrimental role in cardiac aging fea - tures such as hypertrophy and fibrosis (Anderson et al., 2019 ; Baker et al., 2016 ; Lewis-McDougall et al., 2019 ; Zhu et al., 2015).”
BackgroundChronological versus immunological aging: Immune rejuvenation to arrest cognitive decline
Basurco, L., Abellanas, M. A., Purnapatre, M., Antonello, P., & Schwartz, M. (2024) · Neuron · doi:10.1016/j.neuron.2024.12.004 · Cited by 18
Motoji, Y., Fukazawa, R., Matsui, R., Abe, Y., Uehara, I., Watanabe, M., Hashimoto, Y., Miyagi, Y., Nagi‐Miura, N., Tanaka, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416108 · Cited by 15
“Cellular senescence is defined as a stable arrest of the cell cycle, with no growth of proliferatively competent normal cells [21,40,41].”
BackgroundTakaya, K., Asou, T., & Kishi, K. (2022) · Aging · doi:10.18632/aging.204273 · Cited by 19
“It has been reported that p16 functions as a specific marker of senescent cells [9], and in vivo depletion of p16-positive senescent cells significantly improves organ function in aging organisms by suppressing the SASP, extending both healthy and overall life span [21, 22].”
BackgroundThe Dawn of In Vivo Gene Editing Era: A Revolution in the Making
Niazi, S. K. (2023) · Biologics · doi:10.3390/biologics3040014 · Cited by 23
Cellular Senescence in Renal and Urinary Tract Disorders
Santin, Y., Lluel, P., Rischmann, P., Gamé, X., Mialet‐Perez, J., & Parini, A. (2020) · Cells · doi:10.3390/cells9112420 · Cited by 17
Senescence-accelerated mice prone 8 (SAMP8) in male as a spontaneous osteoarthritis model
Sanada, Y., Ikuta, Y., Ding, C., Shinohara, M., Yimiti, D., Ishitobi, H., Nagira, K., Lee, M., Akimoto, T., Shibata, S., et al. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02916-5 · Cited by 21
Sertedaki, E., Veroutis, D., Zagouri, F., Galyfos, G. C., Filis, K., Papalambros, A., Aggeli, K. D., Tsioli, P., Charalambous, G., Zografos, G., et al. (2020) · Current Gerontology and Geriatrics Research · doi:10.1155/2020/8601762 · Cited by 17
Synergistic Anti-Ageing through Senescent Cells Specific Reprogramming
Chen, R., & Skutella, T. (2022) · Cells · doi:10.3390/cells11050830 · Cited by 16
Effect of Nrf2 loss on senescence and cognition of tau-based P301S mice
Riordan, R., Wang, R., Yu, Z., Ross, G., Valerio, J., Dimas-Muñoz, J., Heredia, V., Magnusson, K. R., Galván, V., & Pérez, V. (2023) · GeroScience · doi:10.1007/s11357-023-00760-2 · Cited by 15
“Recently, multiple groups have demonstrated that clearance of senescent cells delays the onset of age-related pathologies (such as physical frailty, loss of endurance, and cognitive decline) in aged mice as well as in tau-based AD mouse models [6, 11, 17].”
BackgroundTran, K. A., Gilbert, M., Vazquez, B. N., Ianni, A., Garcia, B. A., Vaquero, A., & Berger, S. L. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.05.025 · Cited by 15
Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
Cazin, C., Chiche, A., & Li, H. (2017) · Journal of Visualized Experiments · doi:10.3791/56201 · Cited by 20
Effects of Cellular Senescence on Dental Follicle Cells
Morsczeck, C. O. (2020) · Pharmacology · doi:10.1159/000510014 · Cited by 16
Whole brain irradiation–induced endothelial dysfunction in the mouse brain
Kiss, T., Ungvari, A., Gulej, R., Nyúl‐Tóth, Á., Tarantini, S., Benyó, Z., Csík, B., Yabluchanskiy, A., Mukli, P., Csiszár, A., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00990-4 · Cited by 19
Targeting senescent cells in atherosclerosis: Pathways to novel therapies
Tian, Y., Shao, S., Feng, H., Zeng, R., Li, S., & Zhang, Q. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102502 · Cited by 16
Inhibition of glutaminase elicits senolysis in therapy-induced senescent melanoma cells
Kim, J., Brunetti, B., Kumar, A., Mangla, A., Honda, K., & Yoshida, A. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-07284-3 · Cited by 16
“Senolytic therapy is an emerging therapeutic approach that speci fi cally targets and eliminates senescent cells, which prevents cancer recurrence [12 – 15] as well as extending a healthy lifespan in murine models [16, 17].”
Ataabadi, E. A., Golshiri, K., Jüttner, A. A., VRIES, R. D., Garrelds, I. M., Nagtzaam, N. M. A., Khan, H., Leijten, F. P. J., Brandt, R. M. C., Dik, W. A., et al. (2022) · Aging Cell · doi:10.1111/acel.13683 · Cited by 17
“…accelerated ageing rodent models and has led to the development of senolytic drugs, which are not yet applied in the clinic (Baar et al., 2017; Baker et al., 2016; Baker et al., 2011; Tchkonia et al., 2013; Yousefzadeh, Henpita, et al., 2021; Yousefzadeh, Flores, et al., 2021; Yousefzadeh et…”
BackgroundMechanisms of endothelial senescence and vascular aging
Qiao, L., Qian, Z., Huang, Y., Yang, X. F., Yang, J., Xiao, N., Liang, G., Zhang, H., Fu, Y., Yan, L., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10279-y · Cited by 27
“Clearance of p16 Ink4a positive cells prolonged lifespan in the mice model, protected cardiomyocyte function, reduces ageing-associated disorders (Baker et al. 2011, 2016), alleviated multiple diseases including atherosclerosis, type 2 diabetes (Xu et al. 2015).”
Johmura, Y., Yamashita, E., Shimada, M., Nakanishi, K., & Nakanishi, M. (2016) · Scientific Reports · doi:10.1038/srep31194 · Cited by 15
Zhang, Y., Ni, X., Lu, W., Yu, Y., Zhu, B. L., Bai, Y., Pei, X., Gao, F., Guo, L., Yong, Z., et al. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111774 · Cited by 17
Xing, J., Chen, K., Gao, S., Pousse, M., Ying, Y., Wang, B., Chen, L., Wang, C., Wang, L., Hu, W., et al. (2023) · Aging Cell · doi:10.1111/acel.13780 · Cited by 19
“A wealth of recent research indicates that cellular senescence is a basic aging process that greatly contributes to health deterioration and thereby critically impedes healthy aging (Baker et al., 2016; Childs et al., 2017; Song et al., 2020; Tchkonia et al., 2021).”
Backgroundβ-Hydroxybutyrate alleviates cartilage senescence through hnRNP A1-mediated up-regulation of PTEN
Xia, G., Wen, Z., Zhang, L., Huang, J., Wang, X., Liang, C., Cui, X., Cao, X., & Wu, S. J. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112140 · Cited by 16
“Osteoarthritis (OA) is a common age-related disease (ARD) and a major cause of pain and disability in weight-bearing joints of the elderly (Hunter and Bierma-Zeinstra, 2019).”
BackgroundInfluentialHeart of the matter: Mitochondrial dynamics and genome alterations in cardiac aging
Gabillard-Lefort, C., Thibault, T., Lenaers, G., Wiesner, R. J., Mialet‐Perez, J., & Baris, O. R. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112044 · Cited by 17
“…genetic removal of senescent cells reduced cardiac hypertrophy and fibrosis, two main deleterious features of cardiac aging (Anderson et al., 2019), ameliorated the response to stress (Baker et al., 2016) and improved left ventricular remodeling following ischemia-reperfusion (Dookun et al., 2020).”
Autologous NK cells propagated and activated ex vivo decrease senescence markers in human PBMCs
Chelyapov, N. V., Nguyen, T. T., & Gonzalez, R. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101380 · Cited by 22
Recent Advances in Senolysis for Age-Related Diseases
Aratani, S., & Nakanishi, M. (2023) · Physiology · doi:10.1152/physiol.00003.2023 · Cited by 19
Raats, D., Frenkel, N. C., van Schelven, S. J., Rinkes, I. H. M. B., Laoukili, J., & Kranenburg, O. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.87 · Cited by 17
Lau, V. Z., Awogbindin, I. O., Frenkel, D., Whitehead, S. N., & Tremblay, M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70363 · Cited by 15
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.